|
Volumn 374, Issue 17, 2016, Pages 1684-1686
|
The CRISPR way to think about Duchenne's
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOVIRUS VECTOR;
CAS9 PROTEIN;
DYSTROPHIN;
ENDONUCLEASE;
GUIDE RNA;
MESSENGER RNA;
MICRODYSTROPHIN;
OLIGONUCLEOTIDE;
UNCLASSIFIED DRUG;
ALTERNATIVE RNA SPLICING;
CRISPR CAS SYSTEM;
DMD GENE;
DNA SEQUENCE;
DUCHENNE MUSCULAR DYSTROPHY;
ELECTROPORATION;
EXON;
GENE;
GENE MUTATION;
GENE VECTOR;
GENETIC ENGINEERING;
HUMAN;
IMMUNE RESPONSE;
INTRON;
MUSCLE CELL;
MUSCLE FUNCTION;
MUSCLE STEM CELL;
NONHUMAN;
NONSENSE MUTATION;
OPEN READING FRAME;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN SYNTHESIS;
PROTEIN SYNTHESIS INHIBITION;
REVIEW;
RNA TRANSLATION;
VIRAL GENE DELIVERY SYSTEM;
ADENOVIRIDAE;
ANIMAL;
BIOSYNTHESIS;
DISEASE MODEL;
GENETICS;
MOUSE;
MUTATION;
PROCEDURES;
SKELETAL MUSCLE;
ADENOVIRIDAE;
ANIMALS;
CRISPR-CAS SYSTEMS;
DISEASE MODELS, ANIMAL;
DYSTROPHIN;
GENETIC ENGINEERING;
GENETIC VECTORS;
HUMANS;
MICE;
MUSCLE, SKELETAL;
MUSCULAR DYSTROPHY, DUCHENNE;
MUTATION;
PROTEIN BIOSYNTHESIS;
RNA, MESSENGER;
|
EID: 84964988234
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMcibr1601383 Document Type: Review |
Times cited : (13)
|
References (5)
|